FDA 483 Database
FDA Form 483s Issued in October 2025
Every published Form FDA 483 issued in October 2025, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
6
Published 483s in October 2025
6
Distinct firms
Form 483s issued in October 2025
Lonza AGFDA
- FEI
- 3002930340
- Issued
- Oct 28, 2025
- Establishment
- Drug Substance Manufacturer
- Location
- Switzerland
Alps Pharmaceutical Industrial Co., Ltd.FDA
- FEI
- 3002806352
- Issued
- Oct 17, 2025
- Establishment
- Active Pharmaceutical Ingredient Manufacturer
- Location
- Japan
Inotiv Inc.FDA
- FEI
- 1000140135
- Issued
- Oct 24, 2025
- Establishment
- Biopharmaceutics Analytical Facility & Nonclinical Laboratory
- Location
- United States
Lonza Guangzhou Pharmaceutical Ltd.FDA
- FEI
- 3006532186
- Issued
- Oct 31, 2025
- Establishment
- Active Pharmaceutical Ingredient Manufacturer
- Location
- China
SCA Pharmaceuticals IncFDA
- FEI
- 3010683157
- Issued
- Oct 30, 2025
- Establishment
- Outsourcing Facility
- Location
- Arkansas, United States
UBI Pharma Inc.FDA
- FEI
- 3004713402
- Issued
- Oct 14, 2025
- Establishment
- Drug Manufacturer
- Location
- Taiwan
| Company | FEI | Establishment type | Location | Issued | Source |
|---|---|---|---|---|---|
| Lonza AG | 3002930340 | Drug Substance Manufacturer | Switzerland | Oct 28, 2025 | FDA |
| Alps Pharmaceutical Industrial Co., Ltd. | 3002806352 | Active Pharmaceutical Ingredient Manufacturer | Japan | Oct 17, 2025 | FDA |
| Inotiv Inc. | 1000140135 | Biopharmaceutics Analytical Facility & Nonclinical Laboratory | United States | Oct 24, 2025 | FDA |
| Lonza Guangzhou Pharmaceutical Ltd. | 3006532186 | Active Pharmaceutical Ingredient Manufacturer | China | Oct 31, 2025 | FDA |
| SCA Pharmaceuticals Inc | 3010683157 | Outsourcing Facility | Arkansas, United States | Oct 30, 2025 | FDA |
| UBI Pharma Inc. | 3004713402 | Drug Manufacturer | Taiwan | Oct 14, 2025 | FDA |
